Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Tyrosinemia
Tyrosinemia type I
Tyrosinemia type 1 (HTI) is an inborn error of tyrosine catabolism caused by defective activity of fumarylacetoacetate hydrolase (FAH) and is characterized by progressive liver disease, renal tubular dysfunction, porphyria-like crises and a dramatic improvement in prognosis following treatment with nitisinone.
This condition has no sub-types.